Type 2 & other diabetes

Long-term impact of diabetes on mortality in patients undergoing unprotected left main percutaneous coronary intervention (PCI): a propensity score-matched analysis from the BIA-LM registry

Cardiovasc DiabetolPublished Retrospective cohort study

Authors' conclusion

No significant association was observed between diabetes and overall mortality following LMCA PCI. Sensitivity analyses showed worse survival outcomes in diabetic patients treated with two-stent techniques and undergoing non-emergency PCI. These findings suggest the overall safety of PCI for LMCA in people with diabetes and highlight the need for randomized trials, especially investigating indicated high-risk subgroups.

Study context

Population
Patients undergoing unprotected left main coronary artery (LMCA) PCI, December 27, 2007 to February 21, 2022, BIA-LM registry, Poland; median age 71 (63–79) years, 28.2% women
Participants
998 patients214 propensity score-matched (PSM) pairs
Exposure
Diabetes vs no diabetes
  • Diabetesn = 250
Outcome
All-cause mortality
Follow-up
Longest available (mean 4.2 years)
Methodological detailssingle-center registry, propensity score-matched, observational
  • Single-center registry
  • Propensity score-matched
  • Observational

Main finding

As reported in the abstract

All-cause mortality, PSM cohort (214 pairs)

No significant difference in all-cause mortality between groups after PSM (adjusted HR)

1.27

95% CI 0.91–1.77P = 0.16

Observational data: associations, not effects.

Further findings

OutcomeEstimateP value
All-cause mortality, overall cohort · longest available follow-up (mean 4.2 years)Worse prognosis with diabetesHR 1.35 (95% CI 1.03–1.76)P = 0.03
All-cause mortality by subgroup, PSM cohortDiabetesvs ControlWorse outcomes with diabetesHR (two-stent angioplasty) 3.70 (95% CI 1.64–8.34)P = 0.002
All-cause mortality by subgroup, PSM cohortDiabetesvs ControlWorse outcomes with diabetesHR (elective PCI) 2.07 (95% CI 1.29–3.31)P = 0.003
All-cause mortality by subgroup, PSM cohortDiabetesvs ControlBetter survival with diabetesHR (presenting with MI) 0.56 (95% CI 0.35–0.90)P = 0.02
All-cause mortality by subgroup, PSM cohort — No significant difference in outcomes in patients with HF (HR)
1.29 (95% CI 0.88-1.89, P = 0.19)
All-cause mortality by subgroup, PSM cohort — No significant difference in outcomes in patients with CKD (HR)
1.08 (95% CI 0.69-1.71, P = 0.19)
All-cause mortality by subgroup, PSM cohort — No significant difference in outcomes with intravascular imaging use (HR)
1.38 (95% CI 0.70-2.71, P = 0.35)
All-cause mortality by subgroup, PSM cohort — No significant difference in outcomes with concomitant multivessel disease (HR)
1.14 (95% CI 0.75-1.73, P = 0.53)

Original publication

Long-term impact of diabetes on mortality in patients undergoing unprotected left main PCI: a propensity score-matched analysis from the BIA-LM registry. Cardiovasc Diabetol. Published 21 April 2025. doi:10.1186/s12933-025-02733-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.